These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32925340)

  • 1. Bleeding After Musculoskeletal Surgery in Hospitals That Switched From Hydroxyethyl Starch to Albumin Following a Food and Drug Administration Warning.
    Krishnamoorthy V; Ellis AR; McLean DJ; Stefan MS; Nathanson BH; Cobert J; Lindenauer PK; Brookhart MA; Ohnuma T; Raghunathan K
    Anesth Analg; 2020 Oct; 131(4):1193-1200. PubMed ID: 32925340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative colloid choice and bleeding in patients undergoing musculoskeletal surgery: An observational administrative database study.
    Krishnamoorthy V; Motika CO; Ohnuma T; McLean D; Ellis AR; Raghunathan K
    Int J Crit Illn Inj Sci; 2021; 11(4):223-228. PubMed ID: 35070912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin.
    Vogt NH; Bothner U; Lerch G; Lindner KH; Georgieff M
    Anesth Analg; 1996 Aug; 83(2):262-8. PubMed ID: 8694303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of perioperative crystalloid or colloid fluid therapy on hemorrhage, coagulation competence, and outcome: A systematic review and stratified meta-analysis.
    Rasmussen KC; Secher NH; Pedersen T
    Medicine (Baltimore); 2016 Aug; 95(31):e4498. PubMed ID: 27495098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective review.
    Hand WR; Whiteley JR; Epperson TI; Tam L; Crego H; Wolf B; Chavin KD; Taber DJ
    Anesth Analg; 2015 Mar; 120(3):619-626. PubMed ID: 25036375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial.
    Standl T; Lochbuehler H; Galli C; Reich A; Dietrich G; Hagemann H
    Eur J Anaesthesiol; 2008 Jun; 25(6):437-45. PubMed ID: 18339212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare Prescription Drug Plan Formulary Restrictions After Postmarket FDA Black Box Warnings.
    Solotke MT; Ross JS; Shah ND; Karaca-Mandic P; Dhruva SS
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1201-1217. PubMed ID: 31663461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 6% Hydroxyethyl Starch 130/0.4 on Inflammatory Response and Pulmonary Function in Patients Having Cardiac Surgery: A Randomized Clinical Trial.
    Lee MJ; Tannenbaum C; Mao G; Jia Y; Leung S; Yilmaz HO; Ince I; Soltesz E; Duncan AE
    Anesth Analg; 2021 Oct; 133(4):906-914. PubMed ID: 34406128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood transfusion, colloid therapy and the possible saving of albumin volumes during surgery: data analysis of the survey for certified hospitals of the Japanese Society of Anesthesiologists.
    Miyao H;
    J Anesth; 2016 Jun; 30(3):384-90. PubMed ID: 26768898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration.
    Sankar A; Swanson KM; Zhou J; Jena AB; Ross JS; Shah ND; Karaca-Mandic P
    JAMA Netw Open; 2021 Dec; 4(12):e2136662. PubMed ID: 34851398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of perioperative hydroxyethyl starch 6% and albumin 5% in elective joint arthroplasty and association with adverse outcomes: a retrospective population based analysis.
    Opperer M; Poeran J; Rasul R; Mazumdar M; Memtsoudis SG
    BMJ; 2015 Mar; 350():h1567. PubMed ID: 25817299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic comparison of albumin and hydroxyethyl starch in postoperative cardiac surgery patients.
    Moggio RA; Rha CC; Somberg ED; Praeger PI; Pooley RW; Reed GE
    Crit Care Med; 1983 Dec; 11(12):943-5. PubMed ID: 6196155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the haemodynamic effects of 4% succinylated gelatin, 6% hydroxyethyl starch (200/0.5) and 4% human albumin after cardiac surgery.
    Kuitunen A; Suojaranta-Ylinen R; Kukkonen S; Niemi T
    Scand J Surg; 2007; 96(1):72-8. PubMed ID: 17461317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation.
    Multinu F; Casarin J; Hanson KT; Angioni S; Mariani A; Habermann EB; Laughlin-Tommaso SK
    JAMA Surg; 2018 Jun; 153(6):e180141. PubMed ID: 29641835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis.
    Altman C; Bernard B; Roulot D; Vitte RL; Ink O
    Eur J Gastroenterol Hepatol; 1998 Jan; 10(1):5-10. PubMed ID: 9512946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: results from a randomized controlled trial.
    Rasmussen KC; Johansson PI; Højskov M; Kridina I; Kistorp T; Thind P; Nielsen HB; Ruhnau B; Pedersen T; Secher NH
    Ann Surg; 2014 Feb; 259(2):249-54. PubMed ID: 24100337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery.
    Gallandat Huet RC; Siemons AW; Baus D; van Rooyen-Butijn WT; Haagenaars JA; van Oeveren W; Bepperling F
    Can J Anaesth; 2000 Dec; 47(12):1207-15. PubMed ID: 11132743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative renal morbidity and mortality after volume replacement with hydroxyethyl starch 130/0.4 or albumin during surgery: a propensity score-matched study.
    Miyao H; Kotake Y
    J Anesth; 2020 Dec; 34(6):881-891. PubMed ID: 32783070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses.
    Kasper SM; Meinert P; Kampe S; Görg C; Geisen C; Mehlhorn U; Diefenbach C
    Anesthesiology; 2003 Jul; 99(1):42-7. PubMed ID: 12826840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 6% hydroxyethyl starch and 5% albumin for volume replacement therapy in patients undergoing cystectomy (CHART): study protocol for a randomized controlled trial.
    Kammerer T; Klug F; Schwarz M; Hilferink S; Zwissler B; von Dossow V; Karl A; Müller HH; Rehm M
    Trials; 2015 Aug; 16():384. PubMed ID: 26314293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.